Early prediction of immune checkpoint inhibitor-related pneumonitis in advanced non-small cell lung cancer based on primary tumor Delta-radiomics features - Top-Institutions - MDSpire

Early prediction of immune checkpoint inhibitor-related pneumonitis in advanced non-small cell lung cancer based on primary tumor Delta-radiomics features

  • By

  • Xie, Dong

  • Xu, Lingang

  • Xu, Jinxia

  • Chen, Haifeng

  • Yu, Jinna

  • He, Cong

  • Qiu, Yonggang

  • Fu, Linfeng

  • Han, Qiu

  • Kong, Lingting

  • Wu, Fangye

  • May 15, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Radiology
    • Immunotherapy

  • #2

    Dana-Farber/Harvard Cancer Center
    Dana-Farber/Harvard Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Radiology
    • Immunotherapy

  • #3

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Oncology
    • Radiology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology
    • Radiology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Oncology
    • Radiology

Original Source(s)

Early prediction of immune checkpoint inhibitor-related pneumonitis in advanced non-small cell lung cancer based on primary tumor Delta-radiomics features

  • by Xie, Dong , Xu, Lingang , Xu, Jinxia , Chen, Haifeng , Yu, Jinna , He, Cong , Qiu, Yonggang , Fu, Linfeng , Han, Qiu , Kong, Lingting , Wu, Fangye

  • May 15, 2026

Related Content

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship

Synthetic short RNA in cancer

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma